LGND CapEx to Revenue
Ligand Pharmaceuticals Inc · CapEx to Revenue

LGND CapEx to Revenue
Current (TTM)0.10%retrieved
LGND CapEx/Revenue (4.51% → 0.10%)
Latest values, visible window
High-resolution chart · PNG
LGND capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.1686% | |
| 11.7511% | |
| 41.0078% | |
| 9.133% | |
| 3.6271% | |
| 2.7256% | |
| 2.1225% | |
| 4.7273% | |
| 5.0701% | |
| 25.9899% | |
| 15.1055% | |
| 6.9711% | |
| 10.0809% | |
| 27.5392% | |
| 0.2597% | |
| 0.2974% | |
| 1.3405% | |
| 1.8122% | |
| 3.4124% | |
| 1.2649% | |
| 20.1554% | |
| 2.2041% | |
| 1.9718% | |
| 3.2709% | |
| 2.5858% | |
| 2.2552% | |
| 96.577% | |
| 13.5593% | |
| 8.3172% | |
| 1.087% | |
| 0.8163% | |
| 4.5113% |